Aptorum Group Limited (NASDAQ:APM) Short Interest Up 33.3% in August

Aptorum Group Limited (NASDAQ:APM) was the target of a significant increase in short interest in August. As of August 31st, there was short interest totalling 6,000 shares, an increase of 33.3% from the August 15th total of 4,500 shares. Approximately 0.3% of the company’s stock are short sold. Based on an average daily volume of 11,300 shares, the short-interest ratio is presently 0.5 days.

Aptorum Group Price Performance

NASDAQ APM traded up $0.14 during mid-day trading on Friday, reaching $2.88. 11,772 shares of the company’s stock traded hands, compared to its average volume of 876,526. The company has a debt-to-equity ratio of 0.20, a current ratio of 1.18 and a quick ratio of 1.18. Aptorum Group has a 1-year low of $1.35 and a 1-year high of $17.49. The company has a fifty day simple moving average of $3.26 and a 200-day simple moving average of $4.85.

Institutional Trading of Aptorum Group

A hedge fund recently bought a new stake in Aptorum Group stock. Murchinson Ltd. purchased a new position in Aptorum Group Limited (NASDAQ:APM) during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 14,000 shares of the company’s stock, valued at approximately $133,000. Murchinson Ltd. owned about 0.27% of Aptorum Group as of its most recent filing with the Securities and Exchange Commission. Institutional investors and hedge funds own 3.80% of the company’s stock.

About Aptorum Group

Aptorum Group Limited, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of infectious diseases and cancer. The company operates in the Therapeutics and Non-Therapeutics segments. Its pipeline products include SACT- 1 for neuroblastoma and other cancer types; SACT-COV19 for the treatment of coronavirus disease; ALS-4 to treat bacterial infections caused by staphylococcus aureus, including MRSA; and ALS-1 to treat viral infections caused by influenza virus A.